| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 197.909 | 83 |
| GSM780708 | Untreated after 4 days (C2_1) | 208.851 | 84 |
| GSM780709 | Untreated after 4 days (C3_1) | 180.888 | 83 |
| GSM780719 | Untreated after 4 days (C1_2) | 207.413 | 84 |
| GSM780720 | Untreated after 4 days (C2_2) | 234.689 | 85 |
| GSM780721 | Untreated after 4 days (C3_2) | 203.119 | 84 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 248.499 | 86 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 227.769 | 85 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 204.705 | 84 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 228.757 | 85 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 233.175 | 85 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 207.989 | 84 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 191.597 | 83 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 180.461 | 82 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 188.859 | 83 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 208.714 | 84 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 173.312 | 82 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 201.062 | 84 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 317.334 | 88 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 226.987 | 85 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 205.005 | 84 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 284.539 | 87 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 244.872 | 86 |